BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31416473)

  • 1. Assessing the variability and predictability of adipokines (adiponectin, leptin, resistin and their ratios) in non-obese and obese women with anovulatory polycystic ovary syndrome.
    Obirikorang C; Owiredu WKBA; Adu-Afram S; Acheampong E; Asamoah EA; Antwi-Boasiakoh EK; Owiredu EW
    BMC Res Notes; 2019 Aug; 12(1):513. PubMed ID: 31416473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome.
    Sarray S; Madan S; Saleh LR; Mahmoud N; Almawi WY
    Fertil Steril; 2015 Aug; 104(2):460-6. PubMed ID: 26051098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality.
    Baldani DP; Skrgatic L; Kasum M; Zlopasa G; Kralik Oguic S; Herman M
    Gynecol Endocrinol; 2019 May; 35(5):401-405. PubMed ID: 30623695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome.
    Kale-Gurbuz T; Akhan SE; Bastu E; Telci A; Iyibozkurt AC; Topuz S
    J Pediatr Adolesc Gynecol; 2013 Feb; 26(1):27-30. PubMed ID: 23158749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study.
    Liu W; Zhou X; Li Y; Zhang S; Cai X; Zhang R; Gong S; Han X; Ji L
    Medicine (Baltimore); 2020 Feb; 99(6):e19052. PubMed ID: 32028423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin-to-adiponectin, adiponectin-to-leptin ratios, and insulin are specific and sensitive markers associated with polycystic ovary syndrome: a case-control study from Bahrain.
    Golbahar J; Das NM; Al-Ayadhi MA; Gumaa K
    Metab Syndr Relat Disord; 2012 Apr; 10(2):98-102. PubMed ID: 22107332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for altered adipocyte function in polycystic ovary syndrome.
    Carmina E; Orio F; Palomba S; Cascella T; Longo RA; Colao AM; Lombardi G; Lobo RA
    Eur J Endocrinol; 2005 Mar; 152(3):389-94. PubMed ID: 15757855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Kuglin D; Dąbkowska-Huć A; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):51-6. PubMed ID: 20889251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances.
    Olszanecka-Glinianowicz M; Madej P; Nylec M; Owczarek A; Szanecki W; Skałba P; Chudek J
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):238-42. PubMed ID: 23199261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease.
    Atwa M; Emara A; Balata M; Youssef N; Bayoumy N; Sherif A; Fiala L
    Int J Dermatol; 2014 Oct; 53(10):e410-20. PubMed ID: 24168156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].
    Li X; Li X; Huang HY; Ma D; Zhu MW; Lin JF
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2607-10. PubMed ID: 20137676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of rosiglitazone on plasma adiponectin and resistin levels in obese PCO woman--preliminary report].
    Jakubowska J; Bohdanowicz-Pawlak A; Milewicz A
    Przegl Lek; 2007; 64(2):70-3. PubMed ID: 17892035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.
    Silha JV; Krsek M; Skrha JV; Sucharda P; Nyomba BL; Murphy LJ
    Eur J Endocrinol; 2003 Oct; 149(4):331-5. PubMed ID: 14514348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
    Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
    Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women.
    Anderlová K; Kremen J; Dolezalová R; Housová J; Haluzíková D; Kunesová M; Haluzík M
    Physiol Res; 2006; 55(3):277-283. PubMed ID: 16083306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical (adiponectin, leptin, resistin) and new (chemerin, vaspin, omentin) adipocytokines in patients with prediabetes.
    Gateva A; Assyov Y; Tsakova A; Kamenov Z
    Horm Mol Biol Clin Investig; 2018 Jan; 34(1):. PubMed ID: 29332012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.